Skip to main content
Top
Published in: BMC Public Health 1/2019

Open Access 01-12-2019 | Dyslipidemia | Research article

Prevalence and incidence of atherosclerotic cardiovascular disease and its risk factors in Korea: a nationwide population-based study

Authors: Hyungtae Kim, Siin Kim, Sola Han, Pratik P. Rane, Kathleen M. Fox, Yi Qian, Hae Sun Suh

Published in: BMC Public Health | Issue 1/2019

Login to get access

Abstract

Background

Atherosclerotic cardiovascular disease (ASCVD) is the leading cause of death in Korea. According to a report of published by Statistics Korea in 2014, cerebrovascular disease and cardiovascular disease were the major/leading causes of mortality. However, it is more difficult to identify prevalence and incidence of a disease than the mortality owing to the lack of national-level statistics. Few studies have examined the prevalence and incidence of ASCVD and its risk factors since 2012. This study aimed to estimate the prevalence and incidence of ASCVD and its risk factors in Korea using national claims data.

Methods

We conducted a retrospective analysis using the national claims data of the Health Insurance Review and Assessment Service. Patients aged ≥18 years with ASCVD (defined as myocardial infarction, angina, coronary revascularization, peripheral artery disease, ischemic stroke, and transient ischemic attack) were identified between January 1, 2014 and December 31, 2015. Patients at high risk for ASCVD (defined as hypertension, diabetes mellitus, and dyslipidemia without ASCVD during the baseline period) were identified between January 1, 2015 and December 31, 2015. We estimated the prevalence, cumulative incidence, and incidence density. These were further stratified by age and sex. The respective denominators for prevalence and incidence were the census population and the at-risk population (defined as the population without respective disease 1 year prior to the respective disease identification).

Results

Among the included Korean adult patients, the overall prevalence of clinical ASCVD per 1000 individuals was 98.25 in 2014 and 101.11 in 2015. The respective cumulative incidence and incidence density rates of ASCVD per 1000 individuals were 65.30 and 68.03 in 2014, and 67.05 and 69.94 in 2015, respectively. Peripheral artery disease seemed to drive the increase in the total prevalence and incidence of ASCVD. The prevalence and incidence of ASCVD continued to increase with age until 79 years.

Conclusions

This national population-based study confirmed the high prevalence and incidence of ASCVD and its risk factors in the adult population of South Korea. We suggest that more intensive treatment and prevention are needed to prevent ASCVD.
Appendix
Available only for authorised users
Literature
2.
go back to reference Roger VL, Go AS, Lloyd-Jones DM, Benjamin EJ, Berry JD, Borden WB, Bravata DM, Dai S, Ford ES, Fox CS, et al. Heart disease and stroke Statistics-2012 update. Circulation. 2012;125(1):e2–e220.PubMedCrossRef Roger VL, Go AS, Lloyd-Jones DM, Benjamin EJ, Berry JD, Borden WB, Bravata DM, Dai S, Ford ES, Fox CS, et al. Heart disease and stroke Statistics-2012 update. Circulation. 2012;125(1):e2–e220.PubMedCrossRef
3.
go back to reference Shin HY, Lee JY, Song J, Lee S, Lee J, Lim B, Kim H, Huh S. Cause-of-death statistics in the Republic of Korea, 2014. J kor Med Assoc. 2016;59(3):221–32.CrossRef Shin HY, Lee JY, Song J, Lee S, Lee J, Lim B, Kim H, Huh S. Cause-of-death statistics in the Republic of Korea, 2014. J kor Med Assoc. 2016;59(3):221–32.CrossRef
5.
go back to reference Kim KI, Kim MA, Kim MK, Kim SH, Kim HS, Moon MK, Park KS, Park YB, Lim S, Choi SH, et al. 2015 Korean guidelines for the Management of Dyslipidemia: executive summary (English translation). Kor Circulation J. 2016;46(3):275–306.CrossRef Kim KI, Kim MA, Kim MK, Kim SH, Kim HS, Moon MK, Park KS, Park YB, Lim S, Choi SH, et al. 2015 Korean guidelines for the Management of Dyslipidemia: executive summary (English translation). Kor Circulation J. 2016;46(3):275–306.CrossRef
6.
go back to reference Park SW, Kim DJ, Min KW, Baik SH, Choi KM, Park IB, Park JH, Son HS, Ahn CW, Oh J-Y. Current status of diabetes management in Korea using national health insurance database. J Kor Diabetes Assoc. 2007;31(4):362–7.CrossRef Park SW, Kim DJ, Min KW, Baik SH, Choi KM, Park IB, Park JH, Son HS, Ahn CW, Oh J-Y. Current status of diabetes management in Korea using national health insurance database. J Kor Diabetes Assoc. 2007;31(4):362–7.CrossRef
7.
go back to reference Shin J, Park JB, K-i K, Kim JH, Yang DH, Pyun WB, Kim YG, Kim G-H, Chae SC. 2013 Korean Society of Hypertension guidelines for the management of hypertension. Part II—treatments of hypertension. Clin Hypertens. 2015;21(1):2.PubMedPubMedCentralCrossRef Shin J, Park JB, K-i K, Kim JH, Yang DH, Pyun WB, Kim YG, Kim G-H, Chae SC. 2013 Korean Society of Hypertension guidelines for the management of hypertension. Part II—treatments of hypertension. Clin Hypertens. 2015;21(1):2.PubMedPubMedCentralCrossRef
8.
go back to reference Jee SH, Batty GD, Jang Y, Oh DJ, Oh B-H, Lee SH, Park S-W, Seung K-B, Kimm H, Kim SY. The Korean heart study: rationale, objectives, protocol, and preliminary results for a new prospective cohort study of 430,920 men and women. Eur J Prev Cardiol. 2014;21(12):1484–92.PubMedCrossRef Jee SH, Batty GD, Jang Y, Oh DJ, Oh B-H, Lee SH, Park S-W, Seung K-B, Kimm H, Kim SY. The Korean heart study: rationale, objectives, protocol, and preliminary results for a new prospective cohort study of 430,920 men and women. Eur J Prev Cardiol. 2014;21(12):1484–92.PubMedCrossRef
9.
go back to reference Fletcher RH, Fletcher SW, Fletcher GS. Clinical epidemiology: the essentials: Lippincott Williams & Wilkins; 2012. Fletcher RH, Fletcher SW, Fletcher GS. Clinical epidemiology: the essentials: Lippincott Williams & Wilkins; 2012.
10.
11.
go back to reference Kim L, Kim JA, Kim S. A guide for the utilization of Health Insurance Review and Assessment Service national patient samples. Epidemiol Health. 2014;36:e2014008.PubMedPubMedCentralCrossRef Kim L, Kim JA, Kim S. A guide for the utilization of Health Insurance Review and Assessment Service national patient samples. Epidemiol Health. 2014;36:e2014008.PubMedPubMedCentralCrossRef
13.
go back to reference Stone NJ, Merz CNB, ScM F, Blum FCB, McBride FP, Eckel FRH, Schwartz FJS, Goldberg AC, Shero FST. 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults; 2013. Stone NJ, Merz CNB, ScM F, Blum FCB, McBride FP, Eckel FRH, Schwartz FJS, Goldberg AC, Shero FST. 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults; 2013.
14.
go back to reference Committee for Guidelines for Management of Dyslipidemia. Korean guidelines for management of dyslipidemia. Journal of Lipid and Atherosclerosis 2015. 2015;4(1):61–92.CrossRef Committee for Guidelines for Management of Dyslipidemia. Korean guidelines for management of dyslipidemia. Journal of Lipid and Atherosclerosis 2015. 2015;4(1):61–92.CrossRef
15.
go back to reference Expert Panel on Detection E. Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). Jama. 2001;285(19):2486.CrossRef Expert Panel on Detection E. Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). Jama. 2001;285(19):2486.CrossRef
17.
go back to reference Townsend N, Wilson L, Bhatnagar P, Wickramasinghe K, Rayner M, Nichols M. Cardiovascular disease in Europe: epidemiological update 2016. Eur Heart J. 2016;37(42):3232–45.PubMedCrossRef Townsend N, Wilson L, Bhatnagar P, Wickramasinghe K, Rayner M, Nichols M. Cardiovascular disease in Europe: epidemiological update 2016. Eur Heart J. 2016;37(42):3232–45.PubMedCrossRef
18.
go back to reference Gorcyca K, Khan I, Wadhera R, Klimchak A, Song X, Sanchez R, Gooch K. Prevalence of atherosclerotic cardiovascular disease (ASCVD) and diabetes populations in the United States. J Clin Lipidol. 2015;9(3):424.CrossRef Gorcyca K, Khan I, Wadhera R, Klimchak A, Song X, Sanchez R, Gooch K. Prevalence of atherosclerotic cardiovascular disease (ASCVD) and diabetes populations in the United States. J Clin Lipidol. 2015;9(3):424.CrossRef
19.
go back to reference Resnick HE, Lindsay RS, McDermott MM, Devereux RB, Jones KL, Fabsitz RR, Howard BV. Relationship of high and low ankle brachial index to all-cause and cardiovascular disease mortality: the strong heart study. Circulation. 2004;109(6):733–9.PubMedCrossRef Resnick HE, Lindsay RS, McDermott MM, Devereux RB, Jones KL, Fabsitz RR, Howard BV. Relationship of high and low ankle brachial index to all-cause and cardiovascular disease mortality: the strong heart study. Circulation. 2004;109(6):733–9.PubMedCrossRef
20.
go back to reference Heald CL, Fowkes FG, Murray GD, Price JF. Ankle brachial index C. risk of mortality and cardiovascular disease associated with the ankle-brachial index: systematic review. Atherosclerosis. 2006;189(1):61–9.PubMedCrossRef Heald CL, Fowkes FG, Murray GD, Price JF. Ankle brachial index C. risk of mortality and cardiovascular disease associated with the ankle-brachial index: systematic review. Atherosclerosis. 2006;189(1):61–9.PubMedCrossRef
21.
go back to reference Li J, Luo YY, Xu YW, Yang JG, Zheng LQ, Hasimu B, Yu JM, Hu DY. Risk factors of peripheral arterial disease and relationship between low ankle-brachial index and mortality from all-cause and cardiovascular disease in Chinese patients with type 2 diabetes. Circ J. 2007;71(3):377–81.PubMedCrossRef Li J, Luo YY, Xu YW, Yang JG, Zheng LQ, Hasimu B, Yu JM, Hu DY. Risk factors of peripheral arterial disease and relationship between low ankle-brachial index and mortality from all-cause and cardiovascular disease in Chinese patients with type 2 diabetes. Circ J. 2007;71(3):377–81.PubMedCrossRef
22.
go back to reference Criqui MH, McClelland RL, McDermott MM, Allison MA, Blumenthal RS, Aboyans V, Ix JH, Burke GL, Liu K, Shea S. The ankle-brachial index and incident cardiovascular events in the MESA (multi-ethnic study of atherosclerosis). J Am Coll Cardiol. 2010;56(18):1506–12.PubMedPubMedCentralCrossRef Criqui MH, McClelland RL, McDermott MM, Allison MA, Blumenthal RS, Aboyans V, Ix JH, Burke GL, Liu K, Shea S. The ankle-brachial index and incident cardiovascular events in the MESA (multi-ethnic study of atherosclerosis). J Am Coll Cardiol. 2010;56(18):1506–12.PubMedPubMedCentralCrossRef
23.
go back to reference Araki Y, Kumakura H, Kanai H, Kasama S, Sumino H, Ichikawa A, Ito T, Iwasaki T, Takayama Y, Ichikawa S, et al. Prevalence and risk factors for cerebral infarction and carotid artery stenosis in peripheral arterial disease. Atherosclerosis. 2012;223(2):473–7.PubMedCrossRef Araki Y, Kumakura H, Kanai H, Kasama S, Sumino H, Ichikawa A, Ito T, Iwasaki T, Takayama Y, Ichikawa S, et al. Prevalence and risk factors for cerebral infarction and carotid artery stenosis in peripheral arterial disease. Atherosclerosis. 2012;223(2):473–7.PubMedCrossRef
24.
go back to reference Su HM, Lin TH, Hsu PC, Lee CS, Lee WH, Chen SC, Voon WC, Lai WT, Sheu SH. Association of chronic kidney disease and peripheral artery disease with inappropriate left ventricular mass. PLoS One. 2012;7(10):e48422.PubMedPubMedCentralCrossRef Su HM, Lin TH, Hsu PC, Lee CS, Lee WH, Chen SC, Voon WC, Lai WT, Sheu SH. Association of chronic kidney disease and peripheral artery disease with inappropriate left ventricular mass. PLoS One. 2012;7(10):e48422.PubMedPubMedCentralCrossRef
25.
go back to reference Rizvi S, Kamran H, Salciccioli L, Saiful F, Lafferty J, Lazar JM. Relation of the ankle brachial index to left ventricular ejection fraction. Am J Cardiol. 2010;105(1):129–32.PubMedCrossRef Rizvi S, Kamran H, Salciccioli L, Saiful F, Lafferty J, Lazar JM. Relation of the ankle brachial index to left ventricular ejection fraction. Am J Cardiol. 2010;105(1):129–32.PubMedCrossRef
26.
go back to reference Kim EK, Song PS, Yang JH, Song YB, Hahn JY, Choi JH, Gwon HC, Lee SH, Hong KP, Park JE, et al. Peripheral artery disease in korean patients undergoing percutaneous coronary intervention: prevalence and association with coronary artery disease severity. J Korean Med Sci. 2013;28(1):87–92.PubMedPubMedCentralCrossRef Kim EK, Song PS, Yang JH, Song YB, Hahn JY, Choi JH, Gwon HC, Lee SH, Hong KP, Park JE, et al. Peripheral artery disease in korean patients undergoing percutaneous coronary intervention: prevalence and association with coronary artery disease severity. J Korean Med Sci. 2013;28(1):87–92.PubMedPubMedCentralCrossRef
27.
go back to reference Dunbar RL, Mohler ER. The unsung perils of peripheral arterial disease: a malady in search of a patient. Prev Cardiol. 2005;8(2):108–15.PubMedCrossRef Dunbar RL, Mohler ER. The unsung perils of peripheral arterial disease: a malady in search of a patient. Prev Cardiol. 2005;8(2):108–15.PubMedCrossRef
28.
go back to reference Zheng Z-J, Sharrett AR, Chambless LE, Rosamond WD, Nieto FJ, Sheps DS, Dobs A, Evans GW, Heiss G. Associations of ankle-brachial index with clinical coronary heart disease, stroke and preclinical carotid and popliteal atherosclerosis:: the Atherosclerosis Risk in Communities (ARIC) Study. Atherosclerosis. 1997;131(1):115–25.PubMedCrossRef Zheng Z-J, Sharrett AR, Chambless LE, Rosamond WD, Nieto FJ, Sheps DS, Dobs A, Evans GW, Heiss G. Associations of ankle-brachial index with clinical coronary heart disease, stroke and preclinical carotid and popliteal atherosclerosis:: the Atherosclerosis Risk in Communities (ARIC) Study. Atherosclerosis. 1997;131(1):115–25.PubMedCrossRef
29.
go back to reference Ahn S, Park YJ, Min SI, Kim SY, Ha J, Kim SJ, Kim HS, Yoon BW, Min SK. High prevalence of peripheral arterial disease in Korean patients with coronary or cerebrovascular disease. J Korean Med Sci. 2012;27(6):625–9.PubMedPubMedCentralCrossRef Ahn S, Park YJ, Min SI, Kim SY, Ha J, Kim SJ, Kim HS, Yoon BW, Min SK. High prevalence of peripheral arterial disease in Korean patients with coronary or cerebrovascular disease. J Korean Med Sci. 2012;27(6):625–9.PubMedPubMedCentralCrossRef
30.
go back to reference Bhatnagar P, Wickramasinghe K, Wilkins E, Townsend N. Trends in the epidemiology of cardiovascular disease in the UK. Heart. 2016;102(24):1945–52.PubMedCrossRef Bhatnagar P, Wickramasinghe K, Wilkins E, Townsend N. Trends in the epidemiology of cardiovascular disease in the UK. Heart. 2016;102(24):1945–52.PubMedCrossRef
31.
go back to reference Davis KL, Meyers J, Zhao Z, McCollam PL, Murakami M. High-risk atherosclerotic cardiovascular disease in a real-world employed Japanese population: prevalence, cardiovascular event rates, and costs. J Atheroscler Thromb. 2015;22(12):1287–304.PubMedCrossRef Davis KL, Meyers J, Zhao Z, McCollam PL, Murakami M. High-risk atherosclerotic cardiovascular disease in a real-world employed Japanese population: prevalence, cardiovascular event rates, and costs. J Atheroscler Thromb. 2015;22(12):1287–304.PubMedCrossRef
32.
go back to reference Benjamin EJ, Blaha MJ, Chiuve SE, Cushman M, Das SR, Deo R, de Ferranti SD, Floyd J, Fornage M, Gillespie C, et al. Heart disease and stroke statistics—2017 update: a report from the American Heart Association. Circulation. 2017;135(10):e146.PubMedPubMedCentralCrossRef Benjamin EJ, Blaha MJ, Chiuve SE, Cushman M, Das SR, Deo R, de Ferranti SD, Floyd J, Fornage M, Gillespie C, et al. Heart disease and stroke statistics—2017 update: a report from the American Heart Association. Circulation. 2017;135(10):e146.PubMedPubMedCentralCrossRef
33.
go back to reference Goff DC, Lloyd-Jones DM, Bennett G, Coady S, D’Agostino RB, Gibbons R, Greenland P, Lackland DT, Levy D, O’Donnell CJ, et al. 2013 ACC/AHA guideline on the assessment of cardiovascular risk. A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. 2014;129(25 suppl 2):S49–73. Goff DC, Lloyd-Jones DM, Bennett G, Coady S, D’Agostino RB, Gibbons R, Greenland P, Lackland DT, Levy D, O’Donnell CJ, et al. 2013 ACC/AHA guideline on the assessment of cardiovascular risk. A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. 2014;129(25 suppl 2):S49–73.
34.
go back to reference Health NIo. National Heart L, institute B. ATP III guidelines at-a-glance quick desk reference. Washington, DC: US Department of Health and Human Services; 2001. Health NIo. National Heart L, institute B. ATP III guidelines at-a-glance quick desk reference. Washington, DC: US Department of Health and Human Services; 2001.
35.
36.
go back to reference Park BJ, Sung J, Park K, Seo SW, Kim SH. Studying on diagnosis accuracy for health insurance claims data in Korea. Seoul: Seoul National University; 2003. p. 17–29. Park BJ, Sung J, Park K, Seo SW, Kim SH. Studying on diagnosis accuracy for health insurance claims data in Korea. Seoul: Seoul National University; 2003. p. 17–29.
37.
go back to reference Kim JA, Yoon S, Kim LY, Kim DS. Towards actualizing the value potential of Korea health insurance review and assessment (HIRA) data as a resource for Health Research: strengths, limitations, applications, and strategies for optimal use of HIRA data. J Korean Med Sci. 2017;32(5):718–28.PubMedPubMedCentralCrossRef Kim JA, Yoon S, Kim LY, Kim DS. Towards actualizing the value potential of Korea health insurance review and assessment (HIRA) data as a resource for Health Research: strengths, limitations, applications, and strategies for optimal use of HIRA data. J Korean Med Sci. 2017;32(5):718–28.PubMedPubMedCentralCrossRef
38.
go back to reference Kimm H, Yun JE, Lee S-H, Jang Y, Jee SH. Validity of the diagnosis of acute myocardial infarction in korean national medical health insurance claims data: the Korean heart study (1). Korean Circ J. 2012;42(1):10–5.PubMedPubMedCentralCrossRef Kimm H, Yun JE, Lee S-H, Jang Y, Jee SH. Validity of the diagnosis of acute myocardial infarction in korean national medical health insurance claims data: the Korean heart study (1). Korean Circ J. 2012;42(1):10–5.PubMedPubMedCentralCrossRef
39.
go back to reference Kim J. Diabetes in Korea 2007. Korean Diabetes Association Seoul: Health Insurance Review & Assessment Service; 2007. Kim J. Diabetes in Korea 2007. Korean Diabetes Association Seoul: Health Insurance Review & Assessment Service; 2007.
40.
go back to reference Quek RGW, Fox KM, Wang L, Li L, Gandra SR, Wong ND. A US claims-based analysis of real-world lipid-lowering treatment patterns in patients with high cardiovascular disease risk or a previous coronary event. Am J Cardiol. 2016;117(4):495–500.PubMedCrossRef Quek RGW, Fox KM, Wang L, Li L, Gandra SR, Wong ND. A US claims-based analysis of real-world lipid-lowering treatment patterns in patients with high cardiovascular disease risk or a previous coronary event. Am J Cardiol. 2016;117(4):495–500.PubMedCrossRef
41.
go back to reference Choi YJ, Kim JB, Cho SJ, Cho J, Sohn J, Cho SK, Ha KH, Kim C. Changes in the practice of coronary revascularization between 2006 and 2010 in the Republic of Korea. Yonsei Med J. 2015;56(4):895–903.PubMedPubMedCentralCrossRef Choi YJ, Kim JB, Cho SJ, Cho J, Sohn J, Cho SK, Ha KH, Kim C. Changes in the practice of coronary revascularization between 2006 and 2010 in the Republic of Korea. Yonsei Med J. 2015;56(4):895–903.PubMedPubMedCentralCrossRef
42.
go back to reference Kim JY, Kim BO, Kang DH, Bae HJ, Kim HC, Kim MS. Construction of national surveillance system for cardiovascular & cerebrovascular diseases. Seoul: Health Insurance Review & Assessment Service; 2006. Kim JY, Kim BO, Kang DH, Bae HJ, Kim HC, Kim MS. Construction of national surveillance system for cardiovascular & cerebrovascular diseases. Seoul: Health Insurance Review & Assessment Service; 2006.
43.
go back to reference Lee S, Baek K, Chun K. Cost-effectiveness of drug-eluting vs. bare-metal stents in patients with coronary artery disease from the Korean National Health Insurance Database. Yonsei Med J. 2014;55(6):1533–41.PubMedPubMedCentralCrossRef Lee S, Baek K, Chun K. Cost-effectiveness of drug-eluting vs. bare-metal stents in patients with coronary artery disease from the Korean National Health Insurance Database. Yonsei Med J. 2014;55(6):1533–41.PubMedPubMedCentralCrossRef
44.
go back to reference Park YY, Joh JH, Han SA, Kim SH, Cho S, Park HC, Ahn HJ. National trends for the treatment of peripheral arterial disease in Korea between 2004 and 2013. Annals Surg Treat Res. 2015;89(6):319–24.CrossRef Park YY, Joh JH, Han SA, Kim SH, Cho S, Park HC, Ahn HJ. National trends for the treatment of peripheral arterial disease in Korea between 2004 and 2013. Annals Surg Treat Res. 2015;89(6):319–24.CrossRef
45.
go back to reference Abbas S, Ihle P, Köster I, Schubert I. Estimation of disease incidence in claims data dependent on the length of follow-up: a methodological approach. Health Serv Res. 2012;47(2):746–55.PubMedCrossRef Abbas S, Ihle P, Köster I, Schubert I. Estimation of disease incidence in claims data dependent on the length of follow-up: a methodological approach. Health Serv Res. 2012;47(2):746–55.PubMedCrossRef
46.
go back to reference Muennig P, Bounthavong M. Cost-effectiveness analysis in health: a practical approach: John Wiley & Sons; 2016. Muennig P, Bounthavong M. Cost-effectiveness analysis in health: a practical approach: John Wiley & Sons; 2016.
47.
go back to reference Gray AM, Clarke PM, Wolstenholme JL, Wordsworth S. Applied methods of cost-effectiveness analysis in healthcare, vol. 3. Oxford: OUP; 2010. Gray AM, Clarke PM, Wolstenholme JL, Wordsworth S. Applied methods of cost-effectiveness analysis in healthcare, vol. 3. Oxford: OUP; 2010.
48.
go back to reference Finkelstein E, Corso P. Cost-of-illness analyses for policy making: a cautionary tale of use and misuse. Expert Rev Pharmacoecon Outcomes Res. 2003;3(4):367-9.CrossRef Finkelstein E, Corso P. Cost-of-illness analyses for policy making: a cautionary tale of use and misuse. Expert Rev Pharmacoecon Outcomes Res. 2003;3(4):367-9.CrossRef
Metadata
Title
Prevalence and incidence of atherosclerotic cardiovascular disease and its risk factors in Korea: a nationwide population-based study
Authors
Hyungtae Kim
Siin Kim
Sola Han
Pratik P. Rane
Kathleen M. Fox
Yi Qian
Hae Sun Suh
Publication date
01-12-2019
Publisher
BioMed Central
Keyword
Dyslipidemia
Published in
BMC Public Health / Issue 1/2019
Electronic ISSN: 1471-2458
DOI
https://doi.org/10.1186/s12889-019-7439-0

Other articles of this Issue 1/2019

BMC Public Health 1/2019 Go to the issue